Clinical Trial: To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis

U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008547) titled 'To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis' on May 28.

Brief Summary: The goal of this clinical trial is to To evaluate the efficacy of subcutaneous (SC) Netakimab in adult Chinese patients with moderate to severe plaque psoriasis. Researchers will compare Netakimab to placebo to see if Netakimab works to treat plaque psoriasis.

Study Start Date: July 30, 2024

Study Type: INTERVENTIONAL

Condition: Plaque Psoriasis

Intervention: BIOLOGICAL: Netakimab

Netakimab administered subcutaneously

DRUG: Placebo

Placebo administered subcutaneously

Recruitment Status: AC...